Literature DB >> 24559028

Quality standards for real-world research. Focus on observational database studies of comparative effectiveness.

Nicolas Roche1, Helen Reddel, Richard Martin, Guy Brusselle, Alberto Papi, Mike Thomas, Dirjke Postma, Vicky Thomas, Cynthia Rand, Alison Chisholm, David Price.   

Abstract

Real-world research can use observational or clinical trial designs, in both cases putting emphasis on high external validity, to complement the classical efficacy randomized controlled trials (RCTs) with high internal validity. Real-world research is made necessary by the variety of factors that can play an important a role in modulating effectiveness in real life but are often tightly controlled in RCTs, such as comorbidities and concomitant treatments, adherence, inhalation technique, access to care, strength of doctor-caregiver communication, and socio-economic and other organizational factors. Real-world studies belong to two main categories: pragmatic trials and observational studies, which can be prospective or retrospective. Focusing on comparative database observational studies, the process aimed at ensuring high-quality research can be divided into three parts: preparation of research, analyses and reporting, and discussion of results. Key points include a priori planning of data collection and analyses, identification of appropriate database(s), proper outcomes definition, study registration with commitment to publish, bias minimization through matching and adjustment processes accounting for potential confounders, and sensitivity analyses testing the robustness of results. When these conditions are met, observational database studies can reach a sufficient level of evidence to help create guidelines (i.e., clinical and regulatory decision-making).

Mesh:

Year:  2014        PMID: 24559028     DOI: 10.1513/AnnalsATS.201309-300RM

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  54 in total

Review 1.  Randomized controlled trials and neuro-oncology: should alternative designs be considered?

Authors:  Alireza Mansouri; Samuel Shin; Benjamin Cooper; Archita Srivastava; Mohit Bhandari; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2015-08-22       Impact factor: 4.130

2.  Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.

Authors:  David C Klonoff; Alberto Gutierrez; Alexander Fleming; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2019-04-03

Review 3.  Clinical data quality problems and countermeasure for real world study.

Authors:  Runshun Zhang; Yinghui Wang; Baoyan Liu; Guangli Song; Xuezhong Zhou; Shizhen Fan; Xishui Pan
Journal:  Front Med       Date:  2014-08-16       Impact factor: 4.592

4.  2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.

Authors:  Alison Chisholm; Nemr Eid; Bernardino Alcázar-Navarrete; Aji Barot; George Christoff; David B Price
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.

Authors:  Xiaolang Jiang; Longhua Fan; Bin Chen; Junhao Jiang; Jianjun Liu; Guanyu Qiao; Shuai Ju; Yun Shi; Tao Ma; Changpo Lin; Gang Fang; Daqiao Guo; Xin Xu; Zhihui Dong; Weiguo Fu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-16       Impact factor: 2.174

6.  Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease.

Authors:  David B Price; Anna Rigazio; Mary Buatti Small; Thomas J Ferro
Journal:  J Asthma Allergy       Date:  2016-08-26

Review 7.  Addressing Pediatric Obesity in Ambulatory Care: Where Are We and Where Are We Going?

Authors:  Carine M Lenders; Aaron J Manders; Joanna E Perdomo; Kathy A Ireland; Sarah E Barlow
Journal:  Curr Obes Rep       Date:  2016-06

Review 8.  Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence.

Authors:  Shun Lu; Jin-Yuan Shih; Tae-Won Jang; Chong-Kin Liam; Yongfeng Yu
Journal:  Adv Ther       Date:  2021-03-17       Impact factor: 3.845

9.  The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease.

Authors:  Nawar Diar Bakerly; Ashley Woodcock; John P New; J Martin Gibson; Wei Wu; David Leather; Jørgen Vestbo
Journal:  Respir Res       Date:  2015-09-04

Review 10.  Real-world research and its importance in respiratory medicine.

Authors:  David Price; Guy Brusselle; Nicolas Roche; Daryl Freeman; Alison Chisholm
Journal:  Breathe (Sheff)       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.